Oncolytic Reactivation of KSHV as a Therapeutic Approach for Primary Effusion Lymphoma.
Zhou F, Shimoda M, Olney L, Lyu Y, Tran K, Jiang G, Nakano K, Davis RR, Tepper CG, Maverakis E, Campbell M, Li Y, Dandekar S, Izumiya Y.
Zhou F, et al. Among authors: izumiya y.
Mol Cancer Ther. 2017 Nov;16(11):2627-2638. doi: 10.1158/1535-7163.MCT-17-0041. Epub 2017 Aug 28.
Mol Cancer Ther. 2017.
PMID: 28847988
Free PMC article.